-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
LIXTE BIOTECHNOLOGY HOLDINGS, INC. quarterly Accounts Payable, Current history and change rate from Q4 2022 to Q1 2023.
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. Accounts Payable, Current for the quarter ending 31 Mar 2023 was $44,972.
Accounts Payable, Current, Quarterly (USD)